{"page_content": "Free cash flow\nFree cash flow is calculated as the sum of cash flows from operating activities less purchase of property, plant and equipment. A positive free cash flow shows that the Group is able to finance its activities and that external financing or capital raises is thus not necessary for the Group\u2019s operating activities. There-fore, Executive Management believes that this non-IFRS liquidity measure provides useful information to investors in addition to the most directly comparable IFRS financial measure \u201cNet cash flow from operat-ing activities.\u201d The table below shows a reconciliation of free cash flow for 2021, 2020 and 2019:\nDKK thousand\n   2021\n \n2020\n 2019\nCash (outflow)/in\nflow from operating activities\n   -1,211,\n971\n -688\n,716\n -409\n,455\nLess purchase of property, plant and equipment\n   -22,133\n -25\n,044\n -21,\n036\nFree cash flow\n   -1,234\n,104\n -713\n,760\n -430\n,491Alternative performance measures for the Group (non-audited)113\nZealand Pharma  \u221e  Annual Report 2021Par Fin \u2013 Alternative performance measures", "metadata": {"source": "NASDAQ_ZEAL_2021.pdf", "page": 112, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}